NDR2 is critical for osteoclastogenesis by regulating ULK1-mediated mitophagy
JCI Insight · 09.01.2025 · 10 (1)
DOI: 10.1172/jci.insight.180409 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 19.11.2024. Verfasst von Xiangxi Kong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Osteogenesis, Autophagy-Related Protein-1 Homolog, Mitophagy, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Innovative Research Group Project of the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Bone homeostasis primarily stems from the balance between osteoblasts and osteoclasts, wherein an augmented number or heightened activity of osteoclasts is a prevalent etiological factor in the development of bone loss. Nuclear Dbf2-related kinase (NDR2), also known as STK38L, is a member of the Hippo family with serine/threonine kinase activity. We unveiled an upregulation of NDR2 expression during osteoclast differentiation. Manipulation of NDR2 levels through knockdown or overexpression facilitated or hindered osteoclast differentiation, respectively, indicating a negative feedback role for NDR2 in the osteoclastogenesis. Myeloid NDR2-dificient mice ( Lysm + NDR2 fl/fl ) showed lower bone mass and further exacerbated ovariectomy-induced or aging-related bone loss. Mechanically, NDR2 enhanced autophagy and mitophagy through mediating ULK1 instability. In addition, ULK1 inhibitor (ULK1-IN2) ameliorated NDR2 conditional KO–induced bone loss. Finally, we clarified a significant inverse association between NDR2 expression and the occurrence of osteoporosis in patients. The NDR2/ULK1/mitophagy axis is a potential innovative therapeutic target for the prevention and management of bone loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, Hangzhou, China.
- Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Institute of Immunology and Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Wound Healing, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Förderung
- Natural Science Foundation of Zhejiang Province
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Kong, X., Shan, Z., Zhao, Y., Tao, S., Chen, J., Ji, Z., Jin, J., Liu, J., Lin, W., Wang, X. J., Wang, J., Zhao, F., Huang, B., & Chen, J. (2025). NDR2 is critical for osteoclastogenesis by regulating ULK1-mediated mitophagy. JCI Insight, 10(1). https://doi.org/10.1172/jci.insight.180409
Vancouver
Kong X, Shan Z, Zhao Y, Tao S, Chen J, Ji Z, et al. NDR2 is critical for osteoclastogenesis by regulating ULK1-mediated mitophagy. JCI Insight. 2025;10(1). doi:10.1172/jci.insight.180409
BibTeX
@article{Kong2025,
author = {Kong, Xiangxi and Shan, Zhi and Zhao, Yihao and Tao, Siyue and Chen, Jingyun and Ji, Zhongyin and Jin, Jiayan and Liu, Junhui and Lin, Wenlong and Wang, Xiao-Jian and Wang, Jian and Zhao, Fengdong and Huang, Bao and Chen, Jian},
title = {NDR2 is critical for osteoclastogenesis by regulating ULK1-mediated mitophagy},
journal = {JCI Insight},
year = {2025},
volume = {10},
number = {1},
doi = {10.1172/jci.insight.180409}
}
EUVIMED